Express Healthcare
Home  »  News  »  Roche launches cobas infinity edge

Roche launches cobas infinity edge

0 56
Read Article

The platform is designed as an open platform, allowing healthcare professionals to access and adopt third-party innovators’ new digital tools

Roche has introduced cobas® infinity edge, a secure and encrypted cloud-based platform for the integration and management of point of care data, available for use in clinical settings globally.

More people are using digital technologies in health than ever before. Only 15 per cent of healthcare organisations are fully equipped to make quick data-driven decisions due to lack of data integration, multiple incompatible IT systems, and other information silos. With longer life expectancies, and more people living with chronic conditions, healthcare systems face growing pressure to manage more patient data and diagnostic information. Digital health ecosystems can help address these challenges.

The platform supports healthcare professionals in overcoming these challenges by bringing multiple capabilities together in one digital health ecosystem. Using applications, it facilitates professionals’ ability to view and manage patient test results compliantly, while allowing the integration of this data into patients’ electronic medical records (EMRs). It allows deploying new applications in a point of care device, such as the cobas® pulse glucose meter, and connecting patient health information from this device in an easy, timely, secure way to various IT systems. Concurrently, it allows health professionals to access a marketplace of medically relevant applications to drive adoption of digital tools that improve patient care, by leveraging Roche’s network of third party developers. Bringing all of these capabilities together, it breaks down information silos, ultimately driving improved patient care and operational efficiency within and across point of care clinical settings and hospital departments.

Following first commercial availability in select markets, Roche Diagnostics plans to offer the new digital platform in other markets globally throughout 2022 and 2023.

Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
Are you looking for ICP-MS which can increase productivity and remove time trap from your analysis?
Know More